Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. FSD Pharma Inc.
  6. News
  7. Summary
    HUGE   CA35954B2066

FSD PHARMA INC.

(HUGE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

FSD Pharma : Signs Agreement with Covar Pharmaceuticals to Support Development of Lucid-PSYCH

10/19/2021 | 08:52am EST


ę MT Newswires 2021
All news about FSD PHARMA INC.
11/16FSD Pharma Appoints New Member of Research and Clinical Advisory Board
MT
11/16FSD PHARMA : Expands Research and Clinical Advisory Board with Appointment of World-Renown..
PU
11/16FSD Pharma Expands Research and Clinical Advisory Board with Appointment of World-Renow..
BU
11/16FSD Pharma Inc. Appoints Eleanor N. Fish to Its Research and Clinical Advisory Board
CI
11/15FSD PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OP..
PU
10/19FSD PHARMA : Signs Agreement with Covar Pharmaceuticals to Support Development of Lucid-PS..
MT
10/19FSD PHARMA : Signs Agreement with Covar Pharmaceuticals to Support the Development of Luci..
PU
10/19FSD PHARMA : Signs Agreement with Covar Pharmaceuticals to Support the Development of Luci..
BU
10/19FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Luc..
CI
10/18KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Vie..
AQ
More news
Financials
Sales 2020 - - -
Net income 2020 -31,8 M - -
Net cash 2020 17,0 M - -
P/E ratio 2020 -0,75x
Yield 2020 -
Capitalization 52,3 M 52,1 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 9
Free-Float 87,9%
Chart FSD PHARMA INC.
Duration : Period :
FSD Pharma Inc. Technical Analysis Chart | HUGE | CA35954B2066 | MarketScreener
Technical analysis trends FSD PHARMA INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Anthony J. Durkacz Executive Co-Chairman & Chief Executive Officer
Zeeshan Saeed Executive Co-Chairman & President
Nathan Coyle Chief Financial Officer & Controller
Adnan Bashir Independent Director
Donal Carroll Director
Sector and Competitors